Antidepressant-like effects of nicotine and reduced nicotinic receptor binding in the Fawn-Hooded rat, an animal model of co-morbid depression and alcoholism

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 33, Issue 3, 2009, Pages 398-402

  Tizabi, Yousef ^a   Getachew, Bruk ^a   Rezvani, Amir H ^b   Hauser, Sheketha R ^a   Overstreet, David H ^c  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Alcohol intake; Depressive like behavior; FH rat model; Nicotine; Nicotinic receptors

Indexed keywords

ANTIDEPRESSANT AGENT; CYTISINE; NICOTINE TARTRATE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA4BETA2;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORPUS STRIATUM; DEPRESSION; DISEASE ASSOCIATION; DRUG MECHANISM; FAWN HOODED RAT; FORCED SWIMMING TEST; IMMOBILIZATION; MALE; NONHUMAN; RAT; RAT STRAIN; RECEPTOR BINDING; RECEPTOR DENSITY; REINFORCEMENT;

ALCOHOLISM; ALKALOIDS; ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS; AZOCINES; DEPRESSION; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; MALE; NICOTINE; PROTEIN BINDING; QUINOLIZINES; RATS; RATS, INBRED STRAINS; RECEPTORS, NICOTINIC; SWIMMING; TRITIUM;

EID: 62849095533     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2008.09.010     Document Type: Article

References (49)

1. Aulakh C.S., Hill J.L., and Murphy D.L. Attenuation of hypercortisolemia in fawn-hooded rats by antidepressant drugs. Eur J Pharmacol 240 (1993) 85-88
2. Benowitz N.L. Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clin Pharmacol Ther 83 (2008) 531-541
3. Blomqvist O., Ericson M., Johnson D.H., Engel J.A., and Soderpalm B. Voluntary ethanol intake in the rat: effects of nicotinic acetylcholine receptor blockade or subchronic nicotine treatment. Eur J Pharmacol 314 (1996) 257-267
4. Blomqvist O., Hernandez-Avila C.A., Van Kirk J., Rose J.E., and Kranzler H.R. Mecamylamine modifies the pharmacokinetics and reinforcing effects of alcohol. Alcohol Clin Exp Res 26 (2002) 326-331
5. Clark A., Lindgren S., Brooks S.P., Wattson W.P., and Little L.J. Chronic infusion of nicotine can increase operant self-administration of alcohol. Neuropharm 41 (2001) 108-117
6. Chi H., and de Wit H. Mecamylamine attenuates the subjective stimulant-like effects of alcohol in social drinkers. Alcohol Clin Exp Res 27 (2003) 780-786
7. Detke M.J., Rickels M., and Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharm 121 (1995) 66-72
8. Djuric V.J., Dunn E., Overstreet D.H., Dragomir A., and Steiner M. Antidepressant effects of ingested nicotine in female rats of Flinders Resistant and Sensitive Lines. Physiol Behav 67 (1999) 533-537
9. Ericson M., Blomqvist O., Engel J.A., and Soderpalm B. Voluntary ethanol intake in the rat and the associated accumbal dopamine overflow are blocked by ventral tegmental mecamylamine. Eur J Pharmacol 358 (1998) 189-196
10. Ericson M., Lof E., Stomberg R., Chau P., and Soderpalm B. Nicotinic acetylcholine receptors in the anterior, but not posterior, VTA mediate ethanol induced elevation of accumbal dopamine levels. J Pharmacol Exp Ther 326 (2008) 76-82
11. Ferguson S.M., Brodkin J.D., Lloyd G.K., and Menzaghi F. Antidepressant-like effects of the subtype-selective nicotinic acetylcholine receptor agonist, SIB-1508Y, in the learned helplessness rat model of depression. Psychopharm 152 (2000) 295-303
12. Flores C.M., Rogers S.W., Pabreza L.A., Wolfe B.B., and Kellar K.J. A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment. Mol Pharmacol 41 (1992) 31-37
13. Getachew B., Hauser S.R., Taylor R.E., and Tizabi Y. Desipramine blocks alcohol-induced anxiety- and depressive-like behaviors in Wistar-Kyoto (WKY) and Wistar rats. Pharm Biochem Behav 91 (2008) 97-103
14. Gilbert D.G. Depression, smoking, and nicotine: toward a bioinformational situation by trait model. Drug Dev Res 38 (1996) 267-277
15. Glassman A.H. Cigarette smoking: implications for psychiatric illness. Am J Psychiatr 150 (1993) 546-553
16. James H., Tizabi Y., and Taylor R.E. Rapid method for simultaneous measurement of nicotine and cotinine in urine and serum by gas chromatography-mass spectrometry. J Chromatogr B 708 (1998) 87-93
17. Jerlhag E., Grotli M., Luthman K., Svensson L., and Engel J.A. Role of subunit composition of central nicotinic acetylcholine receptors for the stimulatory and dopamine-enhancing effects of ethanol. Alcohol Alcohol 41 (2006) 486-493
18. Jiao X., Paré W.P., and Tejani-Butt S.M. Alcohol consumption alters dopamine transporter sites in Wistar-Kyoto rat brain. Brain Res 1073-1074 (2006) 175-182
19. Koob G.F., and Bloom F.E. Cellular and molecular mechanisms of drug dependence. Science 242 (1988) 715-723
20. Lê A.D., Corrigall W.A., Watchus J., Harding S., Juzytsch W., and Li T.K. Involvement of nicotinic receptors in alcohol self-administration. Alcohol Clin Exp Res 24 (2000) 155-163
21. Lê A.D., Wang A., Harding S., Juzytsch W., and Shaham Y. Nicotine increases alcohol self-administration and reinstates alcohol seeking in rats. Psychopharm 168 (2003) 216-221
22. Li T.K., and Lumeng L. Alcohol preference and voluntary alcohol intakes of inbred rat strains and the National Institutes of Health heterogeneous stock of rats. Alcohol Clin Exp Res 8 (1984) 485-486
23. Lof E., Olausson P., de Bejczy A., Stomberg R., McIntosh J.M., Taylor J.R., et al. Nicotinic acetylcholine receptors in the ventral tegmental area mediate the dopamine activating and reinforcing properties of ethanol cues. Psychopharm 195 (2007) 333-343
24. Lucki I. The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav Pharmacol 8 (1997) 523-532
25. Meyerhoff D.J., Tizabi Y., Staley J.K., Durazzo T.C., Glass J.M., and Nixon S.J. Smoking comorbidity in alcoholism: neurobiological and neurocognitive consequences. Alcohol Clin Exp Res 30 (2006) 253-264
26. Nestby P., Vanderschuren L.J., De Vries T.J., Mulder A.H., Wardeh G., Hogenboom F., et al. Unrestricted free-choice ethanol self-administration in rats causes long-term neuroadaptations in the nucleus accumbens and caudate putamen. Psychopharm 141 (1999) 07-314
27. Overstreet D.H., Rezvani A.H., and Parsian A. Behavioural features of alcohol-preferring rats: focus on inbred strains. Alcohol Alcohol 34 (1999) 378-385
28. Overstreet D.H., Friedman E.F., Mathe' A.M., and Yadid G. The Flinders Sensitive Line rat: a selectively bred putative animal model of depression. Neurosci Biobehav Rev 29 (2005) 739-759
29. Overstreet D.H., Rezvani A.H., and Parsian A. Chronic fluoxetine reduces swim test immobility but not alcohol intake in fawn-hooded rat, an animal model of comorbid depression/alcoholism. Soc Neurosci Abst (2005)
30. Overstreet D.H., Stemmelin J., and Griebel G. Confirmation of antidepressant potential of the selective beta3 adrenoceptor agonist amibegron in an animal model of depression. Pharmacol Biochem Behav 89 (2008) 623-626
31. 3H]cytisine binding to nicotinic cholinergic receptors in brain. Mol Pharmacol 39 (1991) 9-12
32. Pehrson A.L., Philibin S.D., Gross D., Robinson S.E., Vann R.E., Rosecrans J.A., et al. The effects of acute and repeated nicotine doses on spontaneous activity in male and female Sprague Dawley rats: analysis of brain area epibatidine binding and cotinine levels. Pharmacol Biochem Behav 89 (2008) 424-431
33. Porsolt D., Bertin A., and Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229 (1977) 327-336
34. Quattrocki E., Baird A., and Yurgelun-Todd D. Biological aspects of the link between smoking and depression. Harv Rev Psychiatry 8 (2000) 99-110
35. Rezvani A.H., Overstreet D.H., and Janowsky D.S. Genetic serotonin deficiency and alcohol preference in the fawn hooded rats. Alcohol Alcohol 25 (1990) 573-575
36. Rezvani A.H., Parsian A., and Overstreet D.H. The fawn-hooded (FH/Wjd) rat: a genetic animal model of comorbid depression and alcoholism. Psychiatr Genet 12 (2002) 1-16
37. Rezvani A.H., Overstreet D.H., Cleaves M., and Parsian A. Further genetic characterization of the fawn-hooded (FH/Wjd) rat, an animal model of comorbid depression and alcoholism. Psychiat Genet 17 (2007) 77-83
38. Salin-Pascual R.J., Rosas M., Jimenez-Genchi A., Rivera-Meza B.L., and Delgado-Parra V. Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression. J Clin Psychiatry 57 (1996) 387-389
39. Salin-Pascual R.J., and Drucker-Colin R. A novel effect of nicotine on mood and sleep in major depression. NeuroReport 9 (1998) 57-60
40. Semba J., Mataki C., Yamada S., Nankai M., and Toru M. Antidepressant like effects of chronic nicotine on learned helplessness paradigms in rats. Biol Psychiatr 43 (1998) 389-391
41. Soderpalm B., Ericson M., Olausson P., Blomqvist O., and Engel J.A. Nicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol. Behav Brain Res 113 (2000) 85-96
42. Steensland P., Simms J.A., Holgate J., Richards J.K., and Bartlett S.E. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking. Proc Natl Acad Sci USA 104 (2007) 12518-12523
43. Tizabi Y., Overstreet D.H., Rezvani A.H., Louis V.A., Clark Jr. E., Janowsky D.S., et al. Antidepressant effects of nicotine in an animal model of depression. Psychopharm 142 (1999) 193-199
44. Tizabi Y., Rezvani A.H., Russell L.T., Tyler K.Y., and Overstreet D.H. Depressive characteristics of FSL rats: involvement of central nicotinic receptors. Pharmacol Biochem Behav 66 (2000) 73-77
45. Tizabi Y., Getachew B., Davila-Garcia M., and Taylor R.E. Alcohol preference: association with reduced striatal nicotinic receptors. Alcohol Alcohol 36 (2001) 318-322
46. Tizabi Y., Copeland Jr. R.L., Louis V.A., and Taylor R.E. Effects of combined systemic alcohol and central nicotine administration into ventral tegmental area on dopamine release in the nucleus accumbens. Alcohol Clin Exp Res 26 (2002) 394-399
47. Tizabi Y., Bai L., Copeland Jr. R.L., and Taylor R.E. Combined effects of systemic alcohol and nicotine on dopamine release in the nucleus accumbens shell. Alcohol Alcohol 42 (2007) 413-416
48. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci 20 (1997) 92-98
49. Yoshimoto K., Kaneda S., Kawai Y., Ueda S., Takeuchi Y., Matsushita H., et al. Treating rats with 6-hydroxydopamine induced an increase in voluntary alcohol consumption. Alcohol Clin Exp Res 23 Suppl 4 (1999) 2S-6S